Compounds > captopril
Page last updated: 2024-08-23

captopril and Aortic Stenosis

captopril has been researched along with Aortic Stenosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, J; Ma, G; Ma, W; Wang, J; Wang, S; Wu, X1
Baldwin, KM; Bodell, PW; Haddad, F1
Annoni, G; Arosio, B; Bernasconi, R; Bongrani, S; Calvillo, L; Chimenti, S; Gagliano, N; Latini, R; Limana, F; Masson, S; Razzetti, R; Salio, M; Santambrogio, D; Torri, M1
Andreini, I; Bonaduce, D; Casini, A; Condorelli, M; D'Armiento, FP; de Nigris, F; De Rosa, G; Mansueto, G; Napoli, C; Sarlo, F; Somma, P1
Riegger, AJ1

Other Studies

5 other study(ies) available for captopril and Aortic Stenosis

ArticleYear
An experimental study of intravascular stent in abdominal aorta of atherosclerotic miniature pigs.
    Chinese medical journal, 1995, Volume: 108, Issue:7

    Topics: Alloys; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aortic Valve Stenosis; Arteriosclerosis; Captopril; Stents; Swine; Swine, Miniature

1995
Pressure-induced regulation of myosin expression in rodent heart.
    Journal of applied physiology (Bethesda, Md. : 1985), 1995, Volume: 78, Issue:4

    Topics: Animals; Aortic Valve Stenosis; Body Weight; Captopril; Desoxycorticosterone; Female; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Myosins; Nephrectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rodentia

1995
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload.
    Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:2

    Topics: Adrenergic alpha-Agonists; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Captopril; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Renal; Ligation; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes

2001
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
    International journal of cardiology, 2001, Volume: 81, Issue:2-3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Apolipoproteins E; Arteries; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Epitopes; Immunohistochemistry; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptidyl-Dipeptidase A; Random Allocation; Sulfhydryl Reagents; Time Factors; Treatment Outcome

2001
Role of vasopressin in experimental heart failure.
    European heart journal, 1988, Volume: 9 Suppl H

    Topics: Animals; Aortic Valve Stenosis; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Valve Stenosis; Rats; Renin-Angiotensin System; Teprotide; Water-Electrolyte Balance

1988